ITabMed Company
ITabMed's aim of "Innovating for Life" continues, with a focus on the discovery and development of cancer immunotherapy treatments.
Headquarters:
Shanghai,Shanghai,China,Asia
Founded Date:
2020-01-01
Industry:
Advanced BioTech R&D
Employee Number:
11-50
Sub-Industry:
PharmTech
Investors:
3E Bioventures, Yongjin Group, Regent Capital, Binhai Capital
Ipo Status:
private
City:
Shanghai
Region:
Shanghai
Country:
China
Founders:
Yan Xiaoqiang